Fujian Provincial Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1937-01-01

Employees: -

Market Cap: -

Website: https://fjsl.com.cn/

Clinical Trials

The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

Not Applicable

Recruiting

Conditions: Non-Alcoholic Fatty Liver Disease

First Posted Date: 2024-12-05

Last Posted Date: 2024-12-05

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 250

Registration Number: NCT06717828

Locations: 🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

D-TACE-HAIC Combined With Envafolimab and Lenvatinib in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: a Prospective, Single-arm, Phase II Clinical Study

Recruiting

Conditions: Intrahepatic Cholangiocarcinoma

Interventions: Drug: TACE-HAIC, Envafolimab and Lenvatinib

First Posted Date: 2024-10-16

Last Posted Date: 2024-10-16

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 37

Registration Number: NCT06643208

Locations: 🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Not yet recruiting

Conditions: Hepatocellular Carcinoma Non-resectable

First Posted Date: 2024-10-16

Last Posted Date: 2024-10-16

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 15

Registration Number: NCT06643533

Real-world Study of Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Combination Product: TACE, Lenvatinib, combined with Tislelizumab group

First Posted Date: 2024-09-19

Last Posted Date: 2024-10-14

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 20

Registration Number: NCT06602011

Locations: 🇨🇳
First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

and more 3 locations

Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy

Phase 4

Recruiting

Conditions: Behavior Problem

Interventions: Drug: Esketamine hydrochloride
Drug: normal saline

First Posted Date: 2024-08-30

Last Posted Date: 2024-10-01

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 172

Registration Number: NCT06579937

Locations: 🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum

Phase 4

Recruiting

Conditions: Laparoscopic Cholecystectomy

Interventions: Drug: normal Saline
Drug: Dexmedetomidine low-dose
Drug: Dexmedetomidine high-dose

First Posted Date: 2024-08-28

Last Posted Date: 2024-09-30

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 90

Registration Number: NCT06575179

Locations: 🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

Neoadjuvant Triple Therapy for Resectable HCC

Recruiting

Conditions: Resectable Hepatocellular Carcinoma

First Posted Date: 2024-08-26

Last Posted Date: 2024-10-14

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 20

Registration Number: NCT06569498

Locations: 🇨🇳
Fujian provincial hospital, Fuzhou, Fujian, China
🇨🇳
First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China

and more 3 locations

Electroacupuncture for Preventing Postoperative Delirium in Older Adults Undergoing Total Knee Arthroplasty

Not Applicable

Not yet recruiting

Conditions: Postoperative Delirium

Interventions: Device: Disposable acupuncture needles (0.30 × 75 mm)
Device: Placebo needles (0.30 × 25 mm)
Device: SDZ-V electroacupuncture devices

First Posted Date: 2024-08-21

Last Posted Date: 2024-10-01

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 1460

Registration Number: NCT06564506

Locations: 🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China

Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

Recruiting

Conditions: Hepatocellular Carcinoma Non-resectable

Interventions: Combination Product: TACE, Lenvatinib combination with Sintilimab sequential radiotherapy

First Posted Date: 2024-08-20

Last Posted Date: 2024-08-20

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 28

Registration Number: NCT06561399

Locations: 🇨🇳
First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China
🇨🇳
Fujian provincial hospital, Fuzhou, Fujian, China

and more 1 locations

The Effect of Subclinical Dose of Ketamine on Early Postoperative Pain Sensitivity in Patients Undergoing Salpingectomy

Early Phase 1

Not yet recruiting

Conditions: Ectopic Pregnancy

Interventions: Drug: esketamine

First Posted Date: 2024-08-19

Last Posted Date: 2024-08-19

Lead Sponsor: Fujian Provincial Hospital

Target Recruit Count: 60

Registration Number: NCT06559280

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy